| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |